80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
80% 杠杆率，5.5倍 EBITDA： Cresco 是投资者需要的高风险高回报投资吗？
Despite flat earnings and challenging market conditions, Cresco Labs Inc. (OTC:CRLBF) remains an "Overweight" stock, according to analysis firm Zuanic & Associates. In his latest report, Zuanic underscores Cresco's strong positioning in emerging adult-use markets such as Pennsylvania and Ohio while identifying valuation advantages that set the company apart.
分析公司Zuanic & Associates表示，尽管收益持平，市场条件艰难，但Cresco Labs Inc.（场外交易代码：CRLBF）仍然是 “增持” 股票。在最新报告中，Zuanic强调了Cresco在宾夕法尼亚州和俄亥俄州等新兴成人用品市场的强势地位，同时指出了使该公司与众不同的估值优势。
Cresco trades at 5.5x forward EBITDA, below Green Thumb Industries Inc. (OTC:GTBIF) at 7x and Curaleaf Holdings Inc. (OTC:CURLF) at 10x.
Cresco的远期息税折旧摊销前利润为5.5倍，低于Green Thumb Industries Inc.（场外交易代码：GTBIF）的7倍和Curaleaf Holdings Inc.（场外交易代码：CURLF）的10倍。
"This discount presents an appealing entry point for investors looking beyond short-term volatility," Zuanic writes.
祖安尼克写道：“对于那些将目光投向短期波动之外的投资者来说，这种折扣是一个有吸引力的切入点。”
Get Benzinga's exclusive analysis and the top news about the cannabis...
每天在收件箱中免费获取B...
登录免费看全文
登录/注册
资讯热榜
更新时间